About 3 results found for searched term "TAT-GluN2B" (0.14 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41340 | TAT-GluN2BCTM | DAPK |
| TAT-GluN2BCTM is a membrane-permeable DAPK1-targeting peptide that targets active DAPK1 to the lysosome for degradation and protects neurons from oxidative stress and NMDAR-mediated excitotoxicity by knocking down DAPK1. TAT-GluN2BCTM is a membrane-permeable DAPK1-targeting peptide that targets active DAPK1 to lysosomes for degradation, and also protects neurons from oxidative stress and NMDAR-mediated excitotoxicity by knocking down DAPK1. | ||
| M43223 | TAT-GluN2B | Others |
| TAT-GluN2B, a synthetic peptide, is a negative control of Tat-GluN2BCTM (Neuroprotective Agent). | ||
| M56509 | Rislenemdaz | GluR |
| Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
